← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $279K of Karuna Therapeutics, Inc.

Sold$278,600
$111.44Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Tue, Jun 1. Filed Tue, Jun 1, 4:45 PM ET, after the close. Not investment advice.